{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T15:13:43Z","timestamp":1774797223039,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,12,20]],"date-time":"2012-12-20T00:00:00Z","timestamp":1355961600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1245\/s10434-012-2804-6","type":"journal-article","created":{"date-parts":[[2012,12,19]],"date-time":"2012-12-19T00:54:20Z","timestamp":1355878460000},"page":"1530-1537","source":"Crossref","is-referenced-by-count":23,"title":["DNA Ploidy is an Independent Predictor of Survival in Breast Invasive Ductal Carcinoma: A Long-term Multivariate Analysis of 393 Patients"],"prefix":"10.1245","volume":"20","author":[{"given":"Ant\u00f3nio E.","family":"Pinto","sequence":"first","affiliation":[]},{"given":"Teresa","family":"Pereira","sequence":"additional","affiliation":[]},{"given":"M\u00e1rcia","family":"Santos","sequence":"additional","affiliation":[]},{"given":"Mariana","family":"Branco","sequence":"additional","affiliation":[]},{"given":"\u00c2ngelo","family":"Dias","sequence":"additional","affiliation":[]},{"given":"Giovani L.","family":"Silva","sequence":"additional","affiliation":[]},{"given":"M\u00f3nica C.","family":"Ferreira","sequence":"additional","affiliation":[]},{"given":"Saudade","family":"Andr\u00e9","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2012,12,20]]},"reference":[{"key":"2804_CR1","volume-title":"WHO classification of tumours of the breast","year":"2012","unstructured":"Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ, eds. WHO classification of tumours of the breast. 4th ed. Lyon: IARC Press; 2012.","edition":"4"},{"key":"2804_CR2","doi-asserted-by":"crossref","first-page":"R245","DOI":"10.1677\/ERC-10-0136","volume":"17","author":"MT Weigel","year":"2010","unstructured":"Weigel MT, Dowsett M. Current and emerging biomarkers in breast cancer: prognosis and prediction. Endocr Relat Cancer. 2010;17:R245\u201362.","journal-title":"Endocr Relat Cancer."},{"issue":"Suppl 1","key":"2804_CR3","first-page":"S72","volume":"120","author":"JS Ross","year":"2003","unstructured":"Ross JS, Linette GP, Stec J, Ross MS, Anwar S, Boguniewicz A. DNA ploidy and cell cycle analysis in breast cancer. Am J Clin Pathol. 2003;120(Suppl 1):S72\u201384.","journal-title":"Am J Clin Pathol"},{"key":"2804_CR4","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/jcp.52.8.604","volume":"52","author":"AE Pinto","year":"1999","unstructured":"Pinto AE, Andr\u00e9 S, Soares J. Short term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients. J Clin Pathol. 1999;52:604\u201311.","journal-title":"J Clin Pathol."},{"key":"2804_CR5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5301\/JBM.2008.512","volume":"18","author":"AE Pinto","year":"2003","unstructured":"Pinto AE, Andr\u00e9 S, Mendon\u00e7a E, Silva G, Soares J. Overall survival in advanced breast cancer: relevance of progesterone receptor expression and DNA ploidy in fine-needle aspirates of 392 patients. Int J Biol Markers. 2003;18:7\u201312.","journal-title":"Int J Biol Markers."},{"key":"2804_CR6","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1200\/JCO.1993.11.9.1717","volume":"11","author":"O St\u00e5l","year":"1993","unstructured":"St\u00e5l O, Dufmats M, Hatschek T, et al. S-phase fraction is a prognostic factor in stage I breast carcinoma. J Clin Oncol. 1993;11:1717\u201322.","journal-title":"J Clin Oncol."},{"key":"2804_CR7","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/bjc.1995.29","volume":"71","author":"RS Camplejohn","year":"1995","unstructured":"Camplejohn RS, Ash CM, Gillett CE, et al. The prognostic significance of DNA flow cytometry in breast cancer: results from 881 patients treated in a single centre. Br J Cancer. 1995;71:140\u20135.","journal-title":"Br J Cancer."},{"key":"2804_CR8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1023\/A:1006451908322","volume":"62","author":"JJ Michels","year":"2000","unstructured":"Michels JJ, Duigou F, Marnay J. Flow cytometry in primary breast carcinomas. Prognostic impact of proliferative activity. Breast Cancer Res Treat. 2000;62:117\u201326.","journal-title":"Breast Cancer Res Treat."},{"key":"2804_CR9","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/cncr.11916","volume":"100","author":"JJ Michels","year":"2004","unstructured":"Michels JJ, Marnay J, Delozier T, Denoux Y, Chasle J. Proliferative activity in primary breast carcinomas is a salient prognostic factor. Cancer. 2004;100:455\u201364.","journal-title":"Cancer."},{"key":"2804_CR10","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/cncr.21348","volume":"105","author":"P Vielh","year":"2005","unstructured":"Vielh P, Carton M, Padoy E, et al. S-phase fraction as an independent prognostic factor of long-term overall survival in patients with early-stage or locally advanced invasive breast carcinoma. Cancer (Cancer Cytopathol). 2005;105:476\u201382.","journal-title":"Cancer (Cancer Cytopathol)"},{"key":"2804_CR11","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1365-2303.2007.00528.x","volume":"19","author":"B Gazic","year":"2008","unstructured":"Gazic B, Pizem J, Bracko M, et al. S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer\u2014a multivariate study of 770 patients. Cytopathology. 2008;19:294\u2013302.","journal-title":"Cytopathology."},{"key":"2804_CR12","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/bjc.1992.387","volume":"66","author":"PD Stanton","year":"1992","unstructured":"Stanton PD, Cooke TG, Oakes SJ, et al. Lack of prognostic significance of DNA ploidy and S phase fraction in breast cancer. Br J Cancer. 1992;66:925\u20139.","journal-title":"Br J Cancer."},{"key":"2804_CR13","first-page":"762","volume":"10","author":"E Bergers","year":"1997","unstructured":"Bergers E, Baak JPA, van Diest PJ, et al. Prognostic value of DNA ploidy using flow cytometry in 1301 breast cancer patients: results of the prospective Multicenter Morphometric Mammary Carcinoma Project. Mod Pathol. 1997;10:762\u20138.","journal-title":"Mod Pathol."},{"key":"2804_CR14","doi-asserted-by":"crossref","first-page":"364","DOI":"10.5858\/2001-125-0364-TCCLDF","volume":"125","author":"AR Prasad","year":"2001","unstructured":"Prasad AR, Divine G, Zarbo RJ. Two-color, cytokeratin-labeled DNA flow cytometric analysis of 332 breast cancers. Lack of prognostic value with 12-year follow-up. Arch Pathol Lab Med. 2001;125:364\u201374.","journal-title":"Arch Pathol Lab Med."},{"key":"2804_CR15","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1136\/jcp.49.11.931","volume":"49","author":"E Bergers","year":"1996","unstructured":"Bergers E, van Diest PJ, Baak JPA. Tumour heterogeneity of DNA cell cycle variables in breast cancer measured by flow cytometry. J Clin Pathol. 1996;49:931\u20137.","journal-title":"J Clin Pathol."},{"key":"2804_CR16","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/(SICI)1097-0320(19981201)33:4<385::AID-CYTO1>3.0.CO;2-5","volume":"33","author":"B Baldetorp","year":"1998","unstructured":"Baldetorp B, St\u00e5l O, Ahrens O, et al. Swedish Society of Cancer Study Group. Different calculation methods for flow cytometric S-phase fraction: prognostic implications in breast cancer? Cytometry. 1998;33:385\u201395.","journal-title":"Cytometry"},{"key":"2804_CR17","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0046-8177(96)90161-6","volume":"27","author":"E Bergers","year":"1996","unstructured":"Bergers E, Montironi R, van Diest PJ, Prete E, Baak JPA. Interlaboratory reproducibility of semiautomated cell cycle analysis of flow cytometric DNA-histograms obtained from fresh material of 1,295 breast cancer cases. Hum Pathol. 1996;27:553\u201360.","journal-title":"Hum Pathol."},{"key":"2804_CR18","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/cyto.990140505","volume":"14","author":"DW Hedley","year":"1993","unstructured":"Hedley DW, Clark GM, Cornelisse CJ, Killander D, Kute T, Merkel D. Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast. Cytometry. 1993;14:482\u20135.","journal-title":"Cytometry."},{"key":"2804_CR19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1155\/1998\/842306","volume":"17","author":"MG Ormerod","year":"1998","unstructured":"Ormerod MG, Tribukait B, Giaretti W. Consensus report of the task force on standardization of DNA flow cytometry in clinical pathology. Anal Cell Pathol. 1998;17:103\u201310.","journal-title":"Anal Cell Pathol."},{"key":"2804_CR20","first-page":"685","volume":"86","author":"A Chassevent","year":"1999","unstructured":"Chassevent A, Jourdan ML, Ferrero-Pous M, et al. Standardisation et mise en place d\u2019une assurance qualit\u00e9 dans l\u2019\u00e9valuation des param\u00e8tres de prolif\u00e9ration de 1003 cancers du sein T1T2, N0N1, M0: \u00e9tude multicentrique II. ADN-plo\u00efdie et phase de synth\u00e8se d\u2019ADN. Bull Cancer. 1999;86:685\u201391.","journal-title":"Bull Cancer."},{"key":"2804_CR21","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","volume":"19","author":"CW Elston","year":"1991","unstructured":"Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991;19:403\u201310.","journal-title":"Histopathology."},{"key":"2804_CR22","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1177\/30.9.6182188","volume":"30","author":"AD Deitch","year":"1982","unstructured":"Deitch AD, Law H, White RD. A stable propidium iodide staining procedure for flow cytometry. J Histochem Cytochem. 1982;30:967\u201372.","journal-title":"J Histochem Cytochem."},{"key":"2804_CR23","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1083\/jcb.60.2.523","volume":"60","author":"PN Dean","year":"1974","unstructured":"Dean PN, Jett JH. Mathematical analysis of DNA distributions derived from flow microfluorometry. J Cell Biol. 1974;60:523\u20137.","journal-title":"J Cell Biol."},{"key":"2804_CR24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2325\/jbcs.13.249","volume":"13","author":"K Komaki","year":"2006","unstructured":"Komaki K, Sano N, Tanqoku A. Problems in histological grading of malignancy and its clinical significance in patients with operable breast cancer. Breast Cancer. 2006;13:249\u201353.","journal-title":"Breast Cancer."},{"key":"2804_CR25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000094490","volume":"73","author":"AE Pinto","year":"2006","unstructured":"Pinto AE, Andr\u00e9 S, Pereira T, Silva G, Soares J. DNA flow cytometry but not telomerase activity as predictor of disease-free survival in pT1\u20132\/N0\/G2 breast cancer. Pathobiology. 2006;73:63\u201370.","journal-title":"Pathobiology."},{"key":"2804_CR26","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1136\/jcp.50.7.591","volume":"50","author":"AE Pinto","year":"1997","unstructured":"Pinto AE, Andr\u00e9 S, Nogueira M, Mendon\u00e7a E, Soares J. Flow cytometric DNA hypertetraploidy is associated with unfavourable prognostic features in breast cancer. J Clin Pathol. 1997;50:591\u20135.","journal-title":"J Clin Pathol."},{"key":"2804_CR27","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/cyto.b.10040","volume":"55B","author":"JJ Michels","year":"2003","unstructured":"Michels JJ, Duigou F, Marnay J, Denoux Y, Delozier T, Chasle J. Flow cytometry in primary breast carcinomas: prognostic impact of multiploidy and hypoploidy. Cytometry B Clin Cytom. 2003;55B:37\u201345.","journal-title":"Cytometry B Clin Cytom."},{"key":"2804_CR28","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/jcp.2005.027722","volume":"59","author":"AE Pinto","year":"2006","unstructured":"Pinto AE, Roque L, Rodrigues R, Andr\u00e9 S, Soares J. Frequent 7q gains in flow cytometric multiploid\/hypertetraploid breast carcinomas: a study of chromosome imbalances by comparative genomic hybridization. J Clin Pathol. 2006;59:367\u201372.","journal-title":"J Clin Pathol."},{"key":"2804_CR29","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4161\/cbt.9.4.10659","volume":"9","author":"T Megha","year":"2010","unstructured":"Megha T, Neri A, Malagnino V, et al. Traditional and new prognosticators in breast cancer: Nottingham index, MIB-1 and estrogen receptor signaling remain the best predictors of relapse and survival in a series of 289 cases. Cancer Biol Ther. 2010;9:266\u201373.","journal-title":"Cancer Biol Ther."},{"key":"2804_CR30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10549-009-0318-0","volume":"119","author":"S Liu","year":"2010","unstructured":"Liu S, Chia SK, Mehl E, et al. Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients. Breast Cancer Res Treat. 2010;119:53\u201361.","journal-title":"Breast Cancer Res Treat."},{"key":"2804_CR31","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10549-008-0110-6","volume":"115","author":"O Brouckaert","year":"2009","unstructured":"Brouckaert O, Pintens S, Van Belle V, et al. Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors. Breast Cancer Res Treat. 2009;115:349\u201358.","journal-title":"Breast Cancer Res Treat."},{"key":"2804_CR32","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.ejso.2011.08.133","volume":"37","author":"S Liukkonen","year":"2011","unstructured":"Liukkonen S, Leidenius M, Saarto T, Sj\u00f6str\u00f6m-Mattson J. Breast cancer in very young women. Eur J Surg Oncol. 2011;37:1030\u20137.","journal-title":"Eur J Surg Oncol."},{"key":"2804_CR33","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.breast.2011.07.012","volume":"20","author":"R Peng","year":"2011","unstructured":"Peng R, Wang S, Shi Y, et al. Patients 35\u00a0years old or younger with operable breast cancer are more at risk for relapse and survival: a retrospective matched case\u2013control study. Breast. 2011;20:568\u201373.","journal-title":"Breast."},{"key":"2804_CR34","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1002\/1097-0142(20011115)92:10<2523::AID-CNCR1603>3.0.CO;2-6","volume":"92","author":"Q Xiong","year":"2001","unstructured":"Xiong Q, Valero V, Kau V, et al. Female patients with breast carcinoma age 30\u00a0years and younger have a poor prognosis. The MD Anderson Cancer Center Experience. Cancer. 2001;92:2523\u20138.","journal-title":"Cancer."},{"key":"2804_CR35","doi-asserted-by":"crossref","first-page":"8019","DOI":"10.1158\/1078-0432.CCR-08-0974","volume":"14","author":"M Dowsett","year":"2008","unstructured":"Dowsett M, Dunbier AK. Emerging biomarkers and new understanding of traditional markers in personalized therapy for breast cancer. Clin Cancer Res. 2008;14:8019\u201326.","journal-title":"Clin Cancer Res."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-012-2804-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-012-2804-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-012-2804-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T19:47:37Z","timestamp":1643917657000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-012-2804-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,20]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["2804"],"URL":"https:\/\/doi.org\/10.1245\/s10434-012-2804-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,20]]}}}